Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Paul Y Holoye"'
Autor:
Todd Trask, Charlotte Prado, W. Mai, Walter H. Grant, Shiao Y. Woo, Hsin H. Lu, Mark E. Augspurger, Nathan S Floyd, Bin S. Teh, J. Kam Chiu, E. Brian Butler, Philip L. Gildenberg, Paul Y Holoye, L. Steven Carpenter
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 58:721-726
Purpose A pilot study was designed to evaluate the safety and efficacy of a novel regimen of hypofractionated intensity-modulated radiotherapy (RT) in the adjuvant treatment of primary glioblastoma multiforme (GBM). The rationale of the study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbfd13c6b83b3191fbb5fb0b73494fd
https://doi.org/10.1016/s0360-3016(03)01623-7
https://doi.org/10.1016/s0360-3016(03)01623-7
Autor:
Barbara Bowers, Martin N. Raber, Paul Y. Holoye, Becky Hallinan, James Young, Rodger J. Winn, Joseph Readling, Karen Hoelzer, Frank V. Fossella, Waun Ki Hong
Publikováno v:
Investigational New Drugs. 10:331-335
We treated 34 chemotherapy-naive patients with stage IIIb or IV non-small cell lung cancer with trimetrexate 150-200 mg/m2 intravenously over 30 minutes every two weeks. Six of 31 evaluable patients (19%) achieved a partial response. The major toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9173a368950572b741d56ae77273abed
https://doi.org/10.1007/bf00944191
https://doi.org/10.1007/bf00944191
Autor:
Meletios A. Dimopoulos, Naguib A. Samaan, J F Fernandez, Paul Y. Holoye, Rena Vassilopoulou-Sellin
Publikováno v:
Cancer. 69:66-71
The potential role of paraneoplastic Cushing's syndrome (CS) was assessed on the clinical course of patients with small cell lung cancer. A retrospective comparison was done of complications and survival rates according to the presence or absence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58d2f2e1bb006789866a02379fcd1388
https://doi.org/10.1002/1097-0142(19920101)69:1<66::aid-cncr2820690113>3.0.co
https://doi.org/10.1002/1097-0142(19920101)69:1<66::aid-cncr2820690113>3.0.co
Autor:
Jaffer A. Ajani, Ritsuko Komaki, Nancy A. Ellerbroek, Paul Y. Holoye, Tyvin A. Rich, Jack A. Roth, Frank V. Fossella
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 20:351-355
In a dose escalation study, CIS-diamminedichloroplatinum II (cisplatin) was combined with a standard dose of external beam irradiation in 15 patients with localized non-small cell lung cancer (NSCLC) and 16 patients with fixed or recurrent localized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d4eaa05438e2828b7cf1891058b306
https://doi.org/10.1016/0360-3016(91)90119-o
https://doi.org/10.1016/0360-3016(91)90119-o
Autor:
William K. Murphy, Diane Jeffries, Paul Y. Holoye, T. Umsawasdi, J. K. Levy, Dhingra Hm, Martin N. Raber, Jangsoon Lee, Waun Ki Hong, Bonnie S. Glisson
Publikováno v:
American Journal of Clinical Oncology. 13:148-155
Fourteen patients with extensive disease small cell bronchogenic carcinoma (SCBC) received ifosfamide at 2,000 mg/m2/day for 5 consecutive days with simultaneous mesna and vincristine while 26 patients with extensive disease non-small-cell bronchogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b6f9c021744524a34e8539eb260bd2
https://doi.org/10.1097/00000421-199004000-00012
https://doi.org/10.1097/00000421-199004000-00012
Autor:
Paul Y. Holoye, Mihran Shirinian
Publikováno v:
American Journal of Clinical Oncology. 14:251-253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3957adeb8e11b4bc28438dbecfb05c1
https://doi.org/10.1097/00000421-199106000-00013
https://doi.org/10.1097/00000421-199106000-00013
Autor:
Paul Y Holoye, Paolo Angelini
Publikováno v:
Chest. 111(3)
A clinical case is presented illustrating a previously unreported association of (1) neurocardiogenic syncope of new onset in a 57-year-old man, (2) Prinzmetal's angina, and (3) bronchogenic carcinoma of the lung. Initiation of aggressive chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55e5731d8183e894bde46b98c4aca05
https://pubmed.ncbi.nlm.nih.gov/9118728
https://pubmed.ncbi.nlm.nih.gov/9118728
Autor:
Julian Rosenthal, Shaker R. Dakhil, Martin N. Raber, Rodger J. Winn, Dong M. Shin, Roman Perez-Soler, Arthur D. Forman, Paul Y. Holoye, Waun Ki Hong
Publikováno v:
Investigational new drugs. 12(3)
Didemnin B (NSC 325319), a cyclic depsipeptide isolated from a Carribean sea tunicate, exhibited potent antitumor activity in preclinical studies. After determining the maximum tolerated dose in our previous phase I/II trial, we conducted a phase II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10327c88a7d7f694dbde539dc66c57e
https://pubmed.ncbi.nlm.nih.gov/7896544
https://pubmed.ncbi.nlm.nih.gov/7896544
Autor:
Larry Holden, Rodger J. Winn, Karen Harper, Paul Y. Holoye, Heather Allen, Martin N. Raber, Robert Belt, Becky Hallinan, Frank V. Fossella
Publikováno v:
Investigational new drugs. 9(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4c05f94cd63668c92fa6428bb46a75
https://pubmed.ncbi.nlm.nih.gov/1666631
https://pubmed.ncbi.nlm.nih.gov/1666631
Autor:
Bonnie S. Glisson, Clifton F. Mountain, David T. Carr, Paul Y. Holoye, Marion J. McMurtrey, Dhingra Hm, William K. Murphy, Manuel Valdivieso, Jangsoon Lee, T. Umsawasdi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 8(3)
Twenty-six patients with a limited-disease presentation of small-cell bronchogenic carcinoma (SCBC) had surgery after achieving a partial remission with three cycles of chemotherapy. Persistent SCBC was found in 15 patients (58%), non-small-cell bron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9da21483bfe0477830775a5fbc340c9
https://pubmed.ncbi.nlm.nih.gov/2166144
https://pubmed.ncbi.nlm.nih.gov/2166144